Overview

Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The study will examine dexmedetomidine levels in the blood of critically ill intensive care patients to understand how it is broken down by the body.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Dexmedetomidine